Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Repligen ( (RGEN) ) has provided an announcement.
On May 15, 2025, Repligen Corporation held its Annual Meeting of Shareholders, where several key decisions were made. The shareholders elected ten directors to the board, ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, approved the compensation of the company’s executive officers, and sanctioned an amendment to the Certificate of Incorporation to limit the liability of certain officers. These decisions are expected to influence Repligen’s governance and operational strategies moving forward.
The most recent analyst rating on (RGEN) stock is a Buy with a $225.00 price target. To see the full list of analyst forecasts on Repligen stock, see the RGEN Stock Forecast page.
Spark’s Take on RGEN Stock
According to Spark, TipRanks’ AI Analyst, RGEN is a Neutral.
Repligen’s overall stock score reflects a balanced view of its current financial and market conditions. Strengths include a solid balance sheet and optimistic earnings guidance, contrasted by profitability challenges and technical indicators suggesting potential price pressure. Valuation remains a concern due to negative earnings and lack of dividend yield. The earnings call provides a positive outlook, mitigating some financial and valuation concerns. The overall score suggests caution with optimism for future growth.
To see Spark’s full report on RGEN stock, click here.
More about Repligen
Repligen Corporation operates in the biotechnology industry, focusing on the development and commercialization of bioprocessing technologies and systems. The company primarily provides products and services that support the manufacturing of biological drugs, catering to the needs of biopharmaceutical companies globally.
Average Trading Volume: 848,637
Technical Sentiment Signal: Sell
Current Market Cap: $7.39B
For an in-depth examination of RGEN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue